Innate Pharma S.A.

Innate Pharma S.A. is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative immunotherapies for cancer. The company's focus is on harnessing the innate immune system to improve outcomes for cancer patients. Innate Pharma leverages its expertise in natural killer (NK) cell biology and antibody engineering to develop a diverse portfolio of proprietary product candidates. These candidates are designed to target various mechanisms involved in tumor growth and immune evasion. With a commitment to scientific excellence and translational research, Innate Pharma aims to deliver transformative therapies that address unmet medical needs in oncology. The company actively collaborates with leading academic institutions and pharmaceutical partners to accelerate the development and commercialization of its innovative pipeline.